Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - OTHER LONG-TERM ASSETS
Other Long-term Assets LRMR - Larimar Therapeutics, Inc.
659 K
LAST VALUE
-0.75%
2 YEAR CAGR
63.16%
5 YEAR CAGR
-1.19%
10 YEAR CAGR